Researcher.Life Logo

Cancer Biotherapy and Radiopharmaceuticals : Impact Factor & More

eISSN: 1557-8852pISSN: 1084-9785

Key Metrics

CiteScore
5.2
H-Index
66
Impact Factor
< 5
SJR
Q2Oncology
SNIP
0.71
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Biotherapy and Radiopharmaceuticals

Cancer Biotherapy and Radiopharmaceuticals Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher MARY ANN LIEBERT, INC
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Biotherapy and Radiopharmaceuticals ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Biotherapy and Radiopharmaceuticals

Research Progress of Cyclooxygenase-2 in Colorectal Adenomas.
  • 23 Jan 2026
  • Cancer biotherapy & radiopharmaceuticals
Synergistic Effects of Ultrasound and Lenvatinib on Proliferation Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Cells
  • 15 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Neural Decoding of Ultrasound-Modulated Pain States via Deep Learning: Insights from Functional Magnetic Resonance Imaging Data
  • 14 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Ultrasound Radiomic Features for Predicting Postoperative Acute Kidney Injury in Patients with Fractures or Bone Tumors
  • 10 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Ultrasound-Mediated Modulation of circRNA hsa_circ_0004870 as a Prognostic and Therapeutic Biomarker in Pancreatic Cancer
  • 10 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Functionalized Graphene Oxide Nanostructures Enhance Targeted Drug and Gene Delivery, Immunomodulation, Photothermal/Photodynamic Therapy, and Cancer Theranostics.
  • 24 Dec 2025
  • Cancer biotherapy & radiopharmaceuticals
Research Progress of Cyclooxygenase-2 in Colorectal Adenomas.
  • 23 Jan 2026
  • Cancer biotherapy & radiopharmaceuticals
Synergistic Effects of Ultrasound and Lenvatinib on Proliferation Inhibition and Apoptosis Induction in Hepatocellular Carcinoma Cells
  • 15 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Neural Decoding of Ultrasound-Modulated Pain States via Deep Learning: Insights from Functional Magnetic Resonance Imaging Data
  • 14 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Ultrasound Radiomic Features for Predicting Postoperative Acute Kidney Injury in Patients with Fractures or Bone Tumors
  • 10 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Ultrasound-Mediated Modulation of circRNA hsa_circ_0004870 as a Prognostic and Therapeutic Biomarker in Pancreatic Cancer
  • 10 Jan 2026
  • Cancer Biotherapy and Radiopharmaceuticals
Functionalized Graphene Oxide Nanostructures Enhance Targeted Drug and Gene Delivery, Immunomodulation, Photothermal/Photodynamic Therapy, and Cancer Theranostics.
  • 24 Dec 2025
  • Cancer biotherapy & radiopharmaceuticals

FAQs on Cancer Biotherapy and Radiopharmaceuticals